Ferozsons Laboratories Limited (PSX:FEROZ)

Market Cap	12.52B
Revenue (ttm)	16.82B
Net Income (ttm)	689.01M
Shares Out	43.47M
EPS (ttm)	15.85
PE Ratio	18.17
Forward PE	n/a
Dividend	3.00 (0.99%)
Ex-Dividend Date	Oct 18, 2024

Volume	106,836
Average Volume	45,291
Open	299.01
Previous Close	301.54
Day's Range	284.01 - 300.00
52-Week Range	218.00 - 393.00
Beta	0.56
RSI	27.81
Earnings Date	Apr 24, 2025

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally. The company offers products in various therapeutic areas of anti-fungal, anti-viral, antibiotics, cardiometabolic, cough, dermatology, diabetes, gastrointestinal and liver, oncology, orthopedic, and urology and nephrology areas. It also provides medical devices in t...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1954
• Employees: 1,896
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: FEROZ

Financial Performance

In 2024, Ferozsons Laboratories's revenue was 15.85 billion, an increase of 38.38% compared to the previous year's 11.46 billion. Earnings were 683.15 million, an increase of 151.83%.